Distinct pathways for the involvement of WNK4 in the signaling of hypertonicity and EGF

FEBS Journal

Volumn 275, Issue 8, 2008, Pages 1631-1642

  Shaharabany, Miriam ^a   Holtzman, Eliezer J ^a,b   Mayan, Haim ^a,b   Hirschberg, Koret ^b   Seger, Rony ^c   Farfel, Zvi ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cell traffic; EGF; Hypertonicity; Signal transduction; WNK kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; HYPERTONIC SOLUTION; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM CHANNEL; PROTEIN KINASE; PROTEIN KINASE WNK4; SODIUM CHLORIDE COTRANSPORTER;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; GOLGI COMPLEX; HEREDITARY HYPERTENSION; HUMAN; HUMAN CELL; HYPERKALEMIA; LIVER CELL; MICROSCOPY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSEUDOHYPOALDOSTERONISM; SIGNAL TRANSDUCTION;

CELL LINE; CELL SHAPE; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; HYPERTONIC SOLUTIONS; OSMOTIC PRESSURE; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; WNT PROTEINS;

ANURA;

EID: 41549121586     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06318.x     Document Type: Article

References (44)

1. Lifton RP, Gharavi AG Geller DS (2001) Molecular mechanisms of human hypertension. Cell 104, 545 556.
2. Farfel Z, Iaina A, Rosenthal T, Waks U, Shibolet S Gafni J (1978) Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible cell membrane defect. Arch Intern Med 138, 1828 1832.
3. Gordon RD, Klemm SA, Tunny TJ Stowasser M (1995) Gordon's syndrome: a sodium-volume dependent form of hypertension with a genetic basis. In Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn (Laragh JH Brenner BM, eds pp 2111 2123. Raven Press, New York, NY.
4. Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, Holtzman EJ Farfel Z (2004) Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation. J Clin Endocrinol Metab 89, 4025 4030.
5. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard J-M et al. (2001) Human hypertension caused by mutations in WNK kinases. Science 293, 1107 1112.
6. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R Farfel Z (2002) Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia and low bone mineral density. J Clin Endocrinol Metab 87, 3248 3254.
7. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G Lifton RP (2003) Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 100, 680 684.
8. Yang CL, Angell J, Mitchell R Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111, 1039 1045.
9. + secretion. Nat Genet 35, 372 376.
10. + channel in vitro and in vivo. Proc Natl Acad Sci USA 104, 4020 4024.
11. Fu Y, Subramanya A, Rozansky D Cohen DM (2006) WNK kinases influence TRPV4 channel function and localization. Am J Physiol Renal Physiol 290, F1305 F1314.
12. Jiang Y, Ferguson WB Peng J-B (2007) WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am J Physiol Renal Physiol 292, F545 F554.
13. Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, Forbush B, Aronson PS Lifton RP (2004) WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia. Proc Natl Acad Sci USA 101, 2064 2069.
14. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S Uchida S (2004) Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 101, 4690 4694.
15. - permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension. Proc Natl Acad Sci USA 101, 14877 14882.
16. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ et al. (2006) Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38, 1124 1132.
17. Shaul YD Seger R (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773, 1213 1226.
18. Xu B-E, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ Cobb MH (2000) WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 275, 16795 16801.
19. Lenertz LY, Lee B-H, Min X, Xu B-E, Wedin K, Earnest S, Goldsmith EJ Cobb MH (2005) Properties of WNK1 and implications for other family members. J Biol Chem 280, 26653 26658.
20. Xu B-E, Stippec S, Lenertz L, Lee B-H, Zhang W, Lee Y-K Cobb MH (2004) WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J Biol Chem 279, 7826 7831.
21. Hong C, Moorfield KS, Jun P, Aldape KD, Kharbanda S, Phillips HS Costello JF (2007) Epigenome scans and cancer genome sequencing converge on WNK2, a kinase independent suppressor of cell growth. Proc Natl Acad Sci USA 104, 10974 10979.
22. Moniz S, Verissimo F, Matos P, Brazao R, Silva E, Kotevelets LK, Chastre E, Gespach C Jordan P (2007) Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK 1/2. Oncogene 26, 6071 6081.
23. Moriguchi T, Urushiyama S, Hisamoto N, Iemura S-i, Uchida S, Natsume T, Matsumoto K Shibuya H (2005) WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE-related kinases, SPAK and OSR1. J Biol Chem 280, 42685 42693.
24. Vitari AC, Deak M, Morrice NA Alessi DR (2005) The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 391, 17 24.
25. Gagnon KBE, England R Delpire E (2006) Volume sensitivity of cation-Cl-cotransporters is modulated by the interaction of two kinases: Ste-20-related proline-alanine-rich kinase and WNK4. Am J Physiol Cell Physiol 290, C134 C142.
26. Vitari AC, Thastrup J, Rafiqi FH, Deak M, Morrice NA, Karlsson HKR Allessi DR (2006) Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem J 397, 223 231.
27. Wu C, Whiteway M, Thomas DY Leberer E (1995) Molecular characterization of Ste20p, a potential mitogen-activated protein or extracellular signal-regulated kinase kinase (MEK) kinase kinase from Saccharomyces cerevisiae. J Biol Chem 270, 15984 15992.
28. Dan I, Watanabe NM Kusumi A (2001) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 11, 220 230.
29. D561A/+ knockin mouse model. Cell Metab 5, 331 344.
30. Zhou M-j, Lublin DM, Link DC Brown EJ (1995) Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc gamma RII or Fc gamma RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burst. J Biol Chem 270, 13553 13560.
31. Gilbert C, Rollet-Labelle E Naccache PH (2002) Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates. II. A sequential lysis protocol for the analysis of tyrosine phosphorylation-dependent signalling. J Immunol Methods 261, 85 101.
32. Gimenez I (2006) Molecular mechanisms and regulation of furosemide-sensitive Na-K-Cl cotransporters. Curr Opin Nephrol Hypertens 15, 517 523.
33. Zagorska A, Pozo-Guisado E, Boudeau J, Vitari AC, Rafiqi FH, Thastrup J, Deak M, Campbell DG, Morrice NA, Prescott AR et al. (2007) Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress. J Cell Biol 176, 89 100.
34. Dayel MJ, Hom EFY Verkman AS (1999) Diffusion of green fluorescent protein in the aqueous-phase lumen of endoplasmic reticulum. Biophys J 76, 2843 2851.
35. Rotblat B, Yizhar O, Haklai R, Ashery U Kloog Y (2006) Ras and its signals diffuse through the cell on randomly moving nanoparticles. Cancer Res 66, 1974 1981.
36. + channel ROMK1 (Kir1.1). J Physiol 571, 275 286.
37. Shi H, Asher C, Chigaev A, Yung Y, Reuveny E, Seger R Garty H (2002) Interactions of beta and gamma ENaC with Nedd4 can be facilitated by an ERK-mediated phosphorylation. J Biol Chem 277, 13539 13547.
38. Hozawa S, Holtzman EJ Ausiello DA (1996) cAMP motifs regulating transcription in the aquaporin 2 gene. Am J Physiol Cell Physiol 39, C1695 C1702.
39. Nielsen S, Kwon TH, Frokiaer J Agre P (2007) Regulation and dysregulation of aquaporins in water balance disorders. J Intern Med 261, 53 64.
40. Mayan H, Mouallem M, Shaharabany M, Pauzner R Farfel Z (2005) Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension (FHH) with the WNK4 Q565E mutation. Am J Obstet Gynecol 192, 598 603.
41. + transport; study in familial hyperkalemia and hypertension. Eur J Clin Invest 35, 410 415.
42. Boussif O, Lezoualc'h F, Zanta M, Mergny M, Scherman D, Demeneix B Behr J (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92, 7297 7301.
43. Dukhovny A, Goldstein Magal L Hirschberg K (2006) The MAL proteolipid restricts detergent-mediated membrane pore expansion and percolation. Mol Membr Biol 23, 245 257.
44. Rotman-Pikielny P, Hirschberg K, Maruvada P, Suzuki K, Royaux IE, Green ED, Kohn LD, Lippincott-Schwartz J Yen PM (2002) Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum Mol Genet 11, 2625 2633.